Evidence map›Paper›PMID 32521763›Full record

ArticleMetabolites2020

A Novel Function of Sphingosine Kinase 2 in the Metabolism of Sphinga-4,14-Diene Lipids.

Timothy Andrew Couttas, Yepy Hardi Rustam, Huitong Song, Yanfei Qi, Jonathan David Teo, Jinbiao Chen, Gavin Edmund Reid, Anthony Simon Don

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. The Role of Ceramides in Metabolic and Cardiovascular Diseases.Journal of cardiovascular development and disease · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Functional Role of Sphingosine Kinase 2.Frontiers in molecular biosciences · 2021
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Timothy Andrew CouttasCentenary Institute, The University of Sydney, Camperdown, NSW 2006, Australia.
Yepy Hardi RustamDepartment of Biochemistry and Molecular Biology, The University of Melbourne, Melbourne, VIC 3010, Australia.ORCID 0000-0002-1298-9034
Huitong SongCentenary Institute, The University of Sydney, Camperdown, NSW 2006, Australia.
Yanfei QiCentenary Institute, The University of Sydney, Camperdown, NSW 2006, Australia.ORCID 0000-0003-1391-4111
Jonathan David TeoCentenary Institute, The University of Sydney, Camperdown, NSW 2006, Australia.ORCID 0000-0003-3895-8663
Jinbiao ChenCentenary Institute, The University of Sydney, Camperdown, NSW 2006, Australia.ORCID 0000-0003-0339-5880
Gavin Edmund ReidDepartment of Biochemistry and Molecular Biology, The University of Melbourne, Melbourne, VIC 3010, Australia.
Anthony Simon DonCentenary Institute, The University of Sydney, Camperdown, NSW 2006, Australia.ORCID 0000-0003-1655-1184
The University of Sydney · AUThe University of Melbourne · AU

Funding

Australian Research Council DP190102464National Health and Medical Research Council APP1100626National Health and Medical Research Council APP1110400National Health and Medical Research Council APP1156778
6 · The paper itself

Abstract

The number, position, and configuration of double bonds in lipids affect membrane fluidity and the recruitment of signaling proteins. Studies on mammalian sphingolipids have focused on those with a saturated sphinganine or mono-unsaturated sphingosine long chain base. Using high-resolution liquid chromatography-tandem mass spectrometry (LC-MS/MS), we observed a marked accumulation of lipids containing a di-unsaturated sphingadiene base in the hippocampus of mice lacking the metabolic enzyme sphingosine kinase 2 (SphK2). The double bonds were localized to positions C4-C5 and C14-C15 of sphingadiene using ultraviolet photodissociation-tandem mass spectrometry (UVPD-MS/MS). Phosphorylation of sphingoid bases by sphingosine kinase 1 (SphK1) or SphK2 forms the penultimate step in the lysosomal catabolism of all sphingolipids. Both SphK1 and SphK2 phosphorylated sphinga-4,14-diene as efficiently as sphingosine, however deuterated tracer experiments in an oligodendrocyte cell line demonstrated that ceramides with a sphingosine base are more rapidly metabolized than those with a sphingadiene base. Since SphK2 is the dominant sphingosine kinase in brain, we propose that the accumulation of sphingadiene-based lipids in SphK2-deficient brains results from the slower catabolism of these lipids, combined with a bottleneck in the catabolic pathway created by the absence of SphK2. We have therefore uncovered a previously unappreciated role for SphK2 in lipid quality control.

Indexed as

brain lipidsceramidemass spectrometrysphingadienesphingolipidssphingosinesphingosine kinasesphingosine kinase 2SphK2

Identifiers

PMID32521763
PMCPMC7344861
OpenAlexW3033476235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.